MACK DAVID J. bought BTAI
September 30, 2025 · Form 4 insider transaction
MACK DAVID J. bought 1,694 shares of BioXcel Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,694
Price
N/A
Total value
N/A
InsiderMACK DAVID J.
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 30, 2025
Filing dateOctober 1, 2025
Shares owned after18,623
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.